« Back to Record
Citation APA

Sonnenblick, A., Desmedt, C., Neven, P., Loibl, S., Denkert, C., Joensuu, H., Loi, S., Sirtaine, N., Kellokumpu-Lehtinen, P.-L., Piccart-Gebhart, M., Sotiriou, C., Brohée, S., Fumagalli, D., Vincent, D., Venet, D., Ignatiadis, M., Salgado, R., Van den Eynden, G., & Rothé, F. (2015). Constitutive phosphorylated STAT3-associated gene signature is predictive for trastuzumab resistance in primary HER2-positive breast cancer. BMC medicine, 13(1), 177. doi:10.1186/s12916-015-0416-2


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/217653

Sonnenblick, A., Desmedt, C., Neven, P., Loibl, S., Denkert, C., Joensuu, H., Loi, S., Sirtaine, N., Kellokumpu-Lehtinen, P.-L., Piccart-Gebhart, M., Sotiriou, C., Brohée, S., Fumagalli, D., Vincent, D., Venet, D., Ignatiadis, M., Salgado, R., Van den Eynden, G., & Rothé, F. (2015). Constitutive phosphorylated STAT3-associated gene signature is predictive for trastuzumab resistance in primary HER2-positive breast cancer. BMC medicine, 13(1), 177. doi:10.1186/s12916-015-0416-2